Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Of dogs and diagnoses: Does clinical reasoning still matter in an age of biomarkers, functional imaging, and artificial intelligence?

Neuropsychology·2026
Same author

Assessing needs and goals of dementia caregivers: development of the COPE-ING measure.

BMC palliative care·2026
Same author

The Lawton and Brody a half century later: A case for contemporary revision.

The Clinical neuropsychologist·2026
Same author

Relationships Among Dementia, Parental Death, and Other Adverse Childhood Experiences: Systematic Review and Meta-Analysis.

The Journal of neuropsychiatry and clinical neurosciences·2026
Same author

Global scale-free brain activity as a potential neural signature of visual information processing in aging.

Frontiers in aging neuroscience·2026
Same author

Dysphagia Management in Individuals With Parkinson Disease and Cognitive Dysfunction: A Scoping Review.

Archives of physical medicine and rehabilitation·2026

Related Experiment Video

Updated: Jun 2, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Dementia staging across three different methods.

Steve Balsis1, Tyler M Miller, Jared F Benge

  • 1Texas A&M University, College Station, USA. balsis @ tamu.edu

Dementia and Geriatric Cognitive Disorders
|May 11, 2011
PubMed
Summary

Item response theory (IRT) offers the most precise method for staging dementia severity. This approach significantly reduces measurement imprecision compared to traditional methods like the Clinical Dementia Rating Scale algorithm.

More Related Videos

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Related Experiment Videos

Last Updated: Jun 2, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Area of Science:

  • Gerontology
  • Psychometrics
  • Neurology

Background:

  • Dementia staging is crucial for patient management and research.
  • Current staging methods, including the Clinical Dementia Rating (CDR) scale, have limitations in precision.

Purpose of the Study:

  • To evaluate the effectiveness of an item response theory (IRT)-based approach for staging dementia severity.
  • To compare the precision of IRT-based staging against traditional methods.

Main Methods:

  • Item response theory (IRT) models were applied to estimate dementia severity in 1,485 patients.
  • Dementia stages derived from IRT were compared with those from the classic CDR algorithm and the Sum of the Boxes (SOB) approach.

Main Results:

  • Measurement imprecision was 48% with the classic CDR algorithm.
  • Measurement imprecision was 12% with the SOB approach.
  • IRT-based staging demonstrated 0% measurement imprecision, indicating superior accuracy.

Conclusions:

  • The IRT approach weights assessment items based on their ability to differentiate dementia severity, unlike the classic CDR or SOB methods.
  • IRT-based staging provides the most precise method for classifying dementia severity.
  • This advanced methodology enhances the reliability of dementia staging in clinical and research settings.